On July 17, an elderly male passenger suddenly collapsed on the busy Beijing Subway Line 4. In this critical moment, a man in black quickly knelt down to perform CPR. After 5 minutes of intensive rescue, with assistance from concerned passengers and subway sta...

On July 1, 2025, PUMCH launched a medical imaging technology training program for Belt and Road Initiative countries. Sponsored by the Ministry of Commerce and hosted by PUMCH's Department of Radiology, this program draws on the department's advanced imaging t...

The research team led by Director Han Xiaohong and Assistant Director Zheng Xin of the Clinical Pharmacology Research Center at PUMCH, in collaboration with the team led by Deputy Director Ma Mingsheng of Pediatrics and researchers from China University of Min...

On the afternoon of July 11, 2025, XH-02 injection, a proprietary mRNA drug developed by PUMCH, was successfully administered to the first adult patient with hypoparathyroidism (HP). XH-02 injection is the world's first mRNA drug for adult hypoparathyroidism, ...